{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T06:10:22Z","timestamp":1781763022405,"version":"3.54.5"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,5]],"date-time":"2021-01-05T00:00:00Z","timestamp":1609804800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,1,5]],"date-time":"2021-01-05T00:00:00Z","timestamp":1609804800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81671923"],"award-info":[{"award-number":["81671923"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The inactivation of p53 can lead to the formation of pathological scars, including hypertrophic scars and keloids. HOXA5 has been reported to be a critical transcription factor in the p53 pathway in cancers. However, whether HOXA5 also plays a role in pathological scar progression through activating p53 signaling remains unknown. In this study, we first demonstrated that HOXA5 overexpression in hypertrophic scar-or keloids-derived fibroblasts decreased cell proliferation, migration and collagen synthesis, whereas increased cell apoptosis. Furthermore, the results of luciferase activity assays and ChIP PCR assays indicated that HOXA5 transactivated p53 by binding to the ATTA-rich core motif in the p53 promoter. HOXA5 also increased the levels of p21 and Mdm2, which are downstream targets of p53. Interestingly, silencing p53 in these pathological scar-derived fibroblasts partially attenuated HOXA5-mediated growth inhibition effect and HOXA5-induced apoptosis. In addition, 9-cis-retinoic acid augmented the expression of HOXA5 and promoted the effects of HOXA5 on pathological scar-derived fibroblasts, and these effects could be suppressed by HOXA5 knockdown. Thus, our study reveals a role of HOXA5 in mediating the cellular processes of pathological scar-derived fibroblasts by transcriptionally activating the p53 signaling pathway, and 9-cis-retinoic acid may be a potential therapy for pathological scars.<\/jats:p>","DOI":"10.1038\/s41419-020-03323-x","type":"journal-article","created":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T20:09:55Z","timestamp":1610050195000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["HOXA5 counteracts the function of pathological scar-derived fibroblasts by partially activating p53 signaling"],"prefix":"10.1038","volume":"12","author":[{"given":"Yimin","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renpeng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiujun","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danru","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,5]]},"reference":[{"key":"3323_CR1","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/nature07039","volume":"453","author":"GC Gurtner","year":"2008","unstructured":"Gurtner, G. C., Werner, S., Barrandon, Y. & Longaker, M. T. Wound repair and regeneration. Nature 453, 314\u2013321 (2008).","journal-title":"Nature"},{"key":"3323_CR2","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/S1357-2725(98)00058-2","volume":"30","author":"DG Greenhalgh","year":"1998","unstructured":"Greenhalgh, D. G. The role of apoptosis in wound healing. Int J. Biochem. Cell Biol. 30, 1019\u20131030 (1998).","journal-title":"Int J. Biochem. Cell Biol."},{"key":"3323_CR3","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/j.1524-475X.2009.00553.x","volume":"18","author":"B Shih","year":"2010","unstructured":"Shih, B., Garside, E., McGrouther, D. A. & Bayat, A. Molecular dissection of abnormal wound healing processes resulting in keloid disease. Wound Repair Regen. 18, 139\u2013153 (2010).","journal-title":"Wound Repair Regen."},{"key":"3323_CR4","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.jamcollsurg.2007.12.001","volume":"206","author":"PD Butler","year":"2008","unstructured":"Butler, P. D., Longaker, M. T. & Yang, G. P. Current progress in keloid research and treatment. J. Am. Coll. Surg. 206, 731\u2013741 (2008).","journal-title":"J. Am. Coll. Surg."},{"key":"3323_CR5","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1097\/00005373-198310000-00009","volume":"23","author":"EA Deitch","year":"1983","unstructured":"Deitch, E. A., Wheelahan, T. M., Rose, M. P., Clothier, J. & Cotter, J. Hypertrophic burn scars: analysis of variables. J. Trauma 23, 895\u2013898 (1983).","journal-title":"J. Trauma"},{"key":"3323_CR6","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0923-1811(99)00040-7","volume":"22","author":"P Teofoli","year":"1999","unstructured":"Teofoli, P. et al. Expression of Bcl-2, p53, c-jun and c-fos protooncogenes in keloids and hypertrophic scars. J. Dermatol. Sci. 22, 31\u201337 (1999).","journal-title":"J. Dermatol. Sci."},{"key":"3323_CR7","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1038\/s41374-018-0099-3","volume":"98","author":"J Shi","year":"2018","unstructured":"Shi, J. et al. Wild-type p53-modulated autophagy and autophagic fibroblast apoptosis inhibit hypertrophic scar formation. Lab Invest. 98, 1423\u20131437 (2018).","journal-title":"Lab Invest"},{"key":"3323_CR8","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1038\/35016125","volume":"405","author":"V Raman","year":"2000","unstructured":"Raman, V. et al. Compromised HOXA5 function can limit p53 expression in human breast tumours. Nature 405, 974\u2013978 (2000).","journal-title":"Nature"},{"key":"3323_CR9","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1590\/S1517-74912003000100018","volume":"17","author":"FD Nunes","year":"2003","unstructured":"Nunes, F. D., de Almeida, F. C., Tucci, R. & de Sousa, S. C. Homeobox genes: a molecular link between development and cancer. Pesqui. Odontol. Bras. 17, 94\u201398 (2003).","journal-title":"Pesqui. Odontol. Bras."},{"key":"3323_CR10","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.jdermsci.2012.02.019","volume":"66","author":"Y Liang","year":"2012","unstructured":"Liang, Y. et al. HOXA5 inhibits keratinocytes growth and epidermal formation in organotypic cultures in vitro and in vivo. J. Dermatol. Sci. 66, 197\u2013206 (2012).","journal-title":"J. Dermatol. Sci."},{"key":"3323_CR11","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s00403-011-1123-2","volume":"303","author":"M Yang","year":"2011","unstructured":"Yang, M. et al. A preliminary study of differentially expressed genes in expanded skin and normal skin: implications for adult skin regeneration. Arch. Dermatol. Res. 303, 125\u2013133 (2011).","journal-title":"Arch. Dermatol. Res."},{"key":"3323_CR12","doi-asserted-by":"publisher","first-page":"5539","DOI":"10.1038\/onc.2016.95","volume":"35","author":"WW Teo","year":"2016","unstructured":"Teo, W. W. et al. HOXA5 determines cell fate transition and impedes tumor initiation and progression in breast cancer through regulation of E-cadherin and CD24. Oncogene 35, 5539\u20135551 (2016).","journal-title":"Oncogene"},{"key":"3323_CR13","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1016\/j.cellsig.2013.03.015","volume":"25","author":"F Yang","year":"2013","unstructured":"Yang, F., Miao, L., Mei, Y. & Wu, M. Retinoic acid-induced HOXA5 expression is co-regulated by HuR and miR-130a. Cell Signal 25, 1476\u20131485 (2013).","journal-title":"Cell Signal"},{"key":"3323_CR14","doi-asserted-by":"publisher","first-page":"8007","DOI":"10.1158\/0008-5472.CAN-07-1405","volume":"67","author":"H Chen","year":"2007","unstructured":"Chen, H. et al. HOXA5 acts directly downstream of retinoic acid receptor beta and contributes to retinoic acid-induced apoptosis and growth inhibition. Cancer Res. 67, 8007\u20138013 (2007).","journal-title":"Cancer Res."},{"key":"3323_CR15","doi-asserted-by":"publisher","first-page":"tkz003","DOI":"10.1093\/burnst\/tkz003","volume":"27","author":"E Shirakami","year":"2020","unstructured":"Shirakami, E., Yamakawa, S. & Hayashida, K. Strategies to prevent hypertrophic scar formation: a review of therapeutic interventions based on molecular evidence. Burns Trauma 27, tkz003 (2020).","journal-title":"Burns Trauma"},{"key":"3323_CR16","doi-asserted-by":"crossref","unstructured":"Huang C. & Ogawa R. Systemic factors that shape cutaneous pathological scarring. FASEB J, 34, 13171\u201313184 (2020).","DOI":"10.1096\/fj.202001157R"},{"key":"3323_CR17","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1046\/j.1524-475X.1998.60106.x","volume":"6","author":"DA Ladin","year":"1998","unstructured":"Ladin, D. A. et al. p53 and apoptosis alterations in keloids and keloid fibroblasts. Wound Repair Regen. 6, 28\u201337 (1998).","journal-title":"Wound Repair Regen."},{"key":"3323_CR18","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jdermsci.2003.09.005","volume":"34","author":"A Tanaka","year":"2004","unstructured":"Tanaka, A. et al. Expression of p53 family in scars. J. Dermatol. Sci. 34, 17\u201324 (2004).","journal-title":"J. Dermatol. Sci."},{"key":"3323_CR19","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1097\/PRS.0000000000001626","volume":"136","author":"M Chang","year":"2015","unstructured":"Chang, M. et al. Potential molecular mechanisms involved in 5-aminolevulinic acid-based photodynamic therapy against human hypertrophic scars. Plast. Reconstr. Surg. 136, 715\u2013727 (2015).","journal-title":"Plast. Reconstr. Surg."},{"key":"3323_CR20","doi-asserted-by":"publisher","first-page":"3250","DOI":"10.1096\/fj.07-8218com","volume":"21","author":"S Aarabi","year":"2007","unstructured":"Aarabi, S. et al. Mechanical load initiates hypertrophic scar formation through decreased cellular apoptosis. FASEB J. 21, 3250\u20133261 (2007).","journal-title":"FASEB J."},{"key":"3323_CR21","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1111\/j.1365-2133.2010.09939.x","volume":"163","author":"L Huang","year":"2010","unstructured":"Huang, L. et al. Low-dose 5-fluorouracil induces cell cycle G2 arrest and apoptosis in keloid fibroblasts. Br. J. Dermatol. 163, 1181\u20131185 (2010).","journal-title":"Br. J. Dermatol."},{"key":"3323_CR22","doi-asserted-by":"publisher","first-page":"711","DOI":"10.3390\/ijms19030711","volume":"19","author":"HJ Lee","year":"2018","unstructured":"Lee, H. J. & Jang, Y. J. Recent understandings of biology, prophylaxis and treatment strategies for hypertrophic scars and keloids. Int. J. Mol. Sci. 19, 711 (2018).","journal-title":"Int. J. Mol. Sci."},{"key":"3323_CR23","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.burns.2018.08.011","volume":"45","author":"FA Khalid","year":"2019","unstructured":"Khalid, F. A. et al. Comparison of efficacy and safety of intralesional triamcinolone and combination of triamcinolone with 5-fluorouracil in the treatment of keloids and hypertrophic scars: Randomised control trial. Burns 45, 69\u201375 (2019).","journal-title":"Burns"},{"key":"3323_CR24","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1128\/MCB.24.2.924-935.2004","volume":"24","author":"H Chen","year":"2004","unstructured":"Chen, H., Chung, S. & Sukumar, S. HOXA5-induced apoptosis in breast cancer cells is mediated by caspases 2 and 8. Mol. Cell Biol. 24, 924\u2013935 (2004).","journal-title":"Mol. Cell Biol."},{"key":"3323_CR25","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1096\/fasebj.10.9.8801179","volume":"10","author":"H Marshall","year":"1996","unstructured":"Marshall, H., Morrison, A., Studer, M., P\u00f6pperl, H. & Krumlauf, R. Retinoids and Hox genes. FASEB J. 10, 969\u2013978 (1996).","journal-title":"FASEB J."}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-03323-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-03323-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-03323-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T18:43:26Z","timestamp":1669920206000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-03323-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,5]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,1]]}},"alternative-id":["3323"],"URL":"https:\/\/doi.org\/10.1038\/s41419-020-03323-x","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,5]]},"assertion":[{"value":"19 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The experiments were approved by the Shanghai ninth hospital\u2019s Ethical Committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}}],"article-number":"40"}}